Literature DB >> 16490489

Diabetic retinopathy in a multi-ethnic cohort in the United States.

Tien Yin Wong1, Ronald Klein, F M Amirul Islam, Mary Frances Cotch, Aaron R Folsom, Barbara E K Klein, A Richey Sharrett, Steven Shea.   

Abstract

PURPOSE: To describe the prevalence and risk factors of diabetic retinopathy in a multi-ethnic US population of whites, blacks, hispanics, and chinese.
DESIGN: Cross-sectional study of 778 individuals from ages 45 to 85 years with diabetes, participating in the Multi-Ethnic Study of Atherosclerosis (MESA).
METHODS: Retinal photographs were obtained with a 45 degrees nonmydriatic digital fundus camera. Presence and severity of diabetic retinopathy were graded at a central reading center on the basis of a modification of the Airlie House classification system. All participants underwent a standardized interview, examination, and laboratory investigations.
RESULTS: In this population with diabetes, the prevalence of any retinopathy was 33.2% and macular edema 9.0%. The prevalence of any diabetic retinopathy and macular edema was significantly higher in blacks (36.7% and 11.1%) and hispanics (37.4% and 10.7%) than in whites (24.8% and 2.7%) and chinese (25.7% and 8.9%) (P = .01 and P = .007, comparing racial/ethnic differences for retinopathy and macular edema, respectively). Significant independent predictors of any retinopathy were longer duration of diabetes, higher fasting serum glucose, use of diabetic oral medication or insulin, and greater waist-hip ratio. Race was not an independent predictor of any retinopathy.
CONCLUSIONS: This study provides contemporary data on the prevalence of and risk factors for diabetic retinopathy among whites, blacks, hispanics, and chinese participating in the MESA.

Entities:  

Mesh:

Year:  2006        PMID: 16490489      PMCID: PMC2246042          DOI: 10.1016/j.ajo.2005.08.063

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  38 in total

1.  Serum lipids and diabetic retinopathy. Early Treatment Diabetic Retinopathy Study Research Group.

Authors:  F L Ferris; E Y Chew; B J Hoogwerf
Journal:  Diabetes Care       Date:  1996-11       Impact factor: 19.112

2.  Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.

Authors: 
Journal:  Diabetes Care       Date:  1997-07       Impact factor: 19.112

3.  Diabetic retinopathy in Victoria, Australia: the Visual Impairment Project.

Authors:  R McKay; C A McCarty; H R Taylor
Journal:  Br J Ophthalmol       Date:  2000-08       Impact factor: 4.638

4.  Racial and ethnic differences in glycemic control of adults with type 2 diabetes.

Authors:  M I Harris; R C Eastman; C C Cowie; K M Flegal; M S Eberhardt
Journal:  Diabetes Care       Date:  1999-03       Impact factor: 19.112

5.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.

Authors: 
Journal:  BMJ       Date:  1998-09-12

6.  Prevalence of diabetic retinopathy in an older community. The Blue Mountains Eye Study.

Authors:  P Mitchell; W Smith; J J Wang; K Attebo
Journal:  Ophthalmology       Date:  1998-03       Impact factor: 12.079

7.  Is obesity related to microvascular and macrovascular complications in diabetes? The Wisconsin Epidemiologic Study of Diabetic Retinopathy.

Authors:  R Klein; B E Klein; S E Moss
Journal:  Arch Intern Med       Date:  1997-03-24

8.  Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican Americans than in non-Hispanic whites with type 2 diabetes? A U.S. population study.

Authors:  M I Harris; R Klein; C C Cowie; M Rowland; D D Byrd-Holt
Journal:  Diabetes Care       Date:  1998-08       Impact factor: 19.112

9.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

10.  Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22.

Authors:  E Y Chew; M L Klein; F L Ferris; N A Remaley; R P Murphy; K Chantry; B J Hoogwerf; D Miller
Journal:  Arch Ophthalmol       Date:  1996-09
View more
  207 in total

1.  Diabetes eye screening in urban settings serving minority populations: detection of diabetic retinopathy and other ocular findings using telemedicine.

Authors:  Cynthia Owsley; Gerald McGwin; David J Lee; Byron L Lam; David S Friedman; Emily W Gower; Julia A Haller; Lisa A Hark; Jinan Saaddine
Journal:  JAMA Ophthalmol       Date:  2015-02       Impact factor: 7.389

Review 2.  Screening for diabetic retinopathy and diabetic macular edema in the United Kingdom.

Authors:  Tunde Peto; Christine Tadros
Journal:  Curr Diab Rep       Date:  2012-08       Impact factor: 4.810

3.  Diabetic retinopathy and endothelial dysfunction in patients with type 2 diabetes mellitus.

Authors:  Jae-Seung Yun; Seung-Hyun Ko; Ji-Hoon Kim; Keon-Woong Moon; Kun-Woong Moon; Yong-Moon Park; Ki-Dong Yoo; Yu-Bae Ahn
Journal:  Diabetes Metab J       Date:  2013-08-14       Impact factor: 5.376

Review 4.  Prevalence of Diabetic Retinopathy and Vision Loss in the Beijing Eye Study: the Potential Role of the Cerebrospinal Fluid Pressure.

Authors:  Jost B Jonas; Liang Xu; Jie Xu; Wen Bin Wei; Ya Xing Wang
Journal:  Curr Diab Rep       Date:  2015-10       Impact factor: 4.810

Review 5.  Role of Lipids in Retinal Vascular and Macular Disorders.

Authors:  Gunjan Prakash; Rachit Agrawal; Tanie Natung
Journal:  Indian J Clin Biochem       Date:  2016-03-08

6.  Diabetic Retinopathy: Focus on Minority Populations.

Authors:  Arpine Barsegian; Boleslav Kotlyar; Justin Lee; Moro O Salifu; Samy I McFarlane
Journal:  Int J Clin Endocrinol Metab       Date:  2017-11-11

7.  Retinopathy and progression of CKD: The CRIC study.

Authors:  Juan E Grunwald; Maxwell Pistilli; Gui-Shuang Ying; Ebenezer Daniel; Maureen G Maguire; Dawei Xie; Revell Whittock-Martin; Candace Parker Ostroff; Joan C Lo; Raymond R Townsend; Crystal A Gadegbeku; James P Lash; Jeffrey C Fink; Mahboob Rahman; Harold I Feldman; John W Kusek
Journal:  Clin J Am Soc Nephrol       Date:  2014-05-08       Impact factor: 8.237

8.  The chinese american eye study: design and methods.

Authors:  Rohit Varma; Chunyi Hsu; Dandan Wang; Mina Torres; Stanley P Azen
Journal:  Ophthalmic Epidemiol       Date:  2013-09-18       Impact factor: 1.648

9.  Current and future management of diabetic retinopathy: a personalized evidence-based approach.

Authors:  Ryan J Fante; Thomas W Gardner; Jeffrey M Sundstrom
Journal:  Diabetes Manag (Lond)       Date:  2013-11-01

10.  Risk Factors for Proliferative Diabetic Retinopathy in African Americans with Type 2 Diabetes.

Authors:  Alan Penman; Heather Hancock; Evangelia Papavasileiou; Maurice James; Omolola Idowu; Daniel M Riche; Marlene Fernandez; Stacey Brauner; Sataria O Smith; Suzanne Hoadley; Cole Richardson; Vanessa Vazquez; Cheryl Chi; Christopher Andreoli; Deeba Husain; Ching J Chen; Lucia Sobrin
Journal:  Ophthalmic Epidemiol       Date:  2016-03-07       Impact factor: 1.648

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.